Immune Therapeutics, Inc. is a biotechnology company developing and seeking to commercialize patented therapies in emerging nations that combat chronic, life threatening diseases by stimulating or rebalancing the immune system. Our technology platform is based on two interrelated cytokine drug therapies Low Dose Naltrexone LDN and Methionine Enkephalin MENK which work by triggering opioid receptors on immune cells to activate various cells of the immune system.
Quote | Immune Therapeutics (OTCMKTS:IMUN)
Last: | $0.093 |
---|---|
Change Percent: | 100.0% |
Open: | $0 |
Close: | $0.093 |
High: | $0 |
Low: | $0 |
Volume: | 12 |
Last Trade Date Time: | 12/31/1969 07:00:00 pm |
News | Immune Therapeutics (OTCMKTS:IMUN)
Orlando, FL, Sept. 14, 2023 (GLOBE NEWSWIRE) -- Immune Therapeutics, Inc. d/b/a Biostax Corp (OTC Pink: IMUN) (“Biostax”), a hub and spoke biotech development engine, sadly announces the passing of H. Louis Salomonksy, a dedicated member of its Board of Directors. Mr. Salomonksy pas...
2023-08-29 11:20:56 ET More on Immune Therapeutics, Inc. Immune to rename as Biostax, outlines strategic plans Statera Biopharma soars after co says to sell rights to naltrexone to Immune Therapeutics Immune Therapeutics announces financing and debt restructuring pla...
Message Board Posts | Immune Therapeutics (OTCMKTS:IMUN)
Subject | By | Source | When |
---|---|---|---|
STAB did close to $75m in dollar volume. | rwalto | investorshub | 04/29/2022 8:36:49 PM |
at the end ofthe day.$ STAB was up | goforthebet | investorshub | 04/29/2022 6:11:42 AM |
Absolutely pathetic that this ticker barely moved today | rwalto | investorshub | 04/28/2022 8:22:37 PM |
Statera Biopharma (Nasdaq: $STAB) (the "Company"), a leading | Herold | investorshub | 04/27/2022 8:31:43 PM |
#DDAmanda Chart on: $IMUN up 100% : | TraderStig | investorshub | 12/20/2021 11:46:18 PM |
News, Short Squeeze, Breakout and More Instantly...
Orlando, FL, Sept. 14, 2023 (GLOBE NEWSWIRE) -- Immune Therapeutics, Inc. d/b/a Biostax Corp (OTC Pink: IMUN) (“Biostax”), a hub and spoke biotech development engine, sadly announces the passing of H. Louis Salomonksy, a dedicated member of its Board of Directors. Mr. Salomonksy pas...
Orlando, FL, Aug. 29, 2023 (GLOBE NEWSWIRE) -- Immune Therapeutics, Inc. d/b/a Biostax Corp . (OTC Pink: IMUN) (“Biostax”), a hub-and-spoke biotech development engine, announces the signing of a research collaboration agreement with Immgenuity, Inc . The joint resear...
Orlando, FL, Aug. 15, 2023 (GLOBE NEWSWIRE) -- Immune Therapeutics, Inc. d/b/a Biostax Corp. (OTC Pink: IMUN) ("Biostax"), a hub-and-spoke biotech development engine, announces that they have accepted the transfer of three Investigational New Drug Applications (IND) for the drug candidate, JKB-12...